Kittiratchakool, N., Kulpokin, D., Chanjam, C., Vilaiyuk, S., Charuvanij, S., Phongsamart, G., . . . Leelahavarong, P. Cost–utility and budget impact analysis of tocilizumab for the treatment of refractory systemic juvenile idiopathic arthritis in Thailand. BMJ Publishing Group.
Chicago Style (17th ed.) CitationKittiratchakool, Nitichen, et al. Cost–utility and Budget Impact Analysis of Tocilizumab for the Treatment of Refractory Systemic Juvenile Idiopathic Arthritis in Thailand. BMJ Publishing Group.
MLA (9th ed.) CitationKittiratchakool, Nitichen, et al. Cost–utility and Budget Impact Analysis of Tocilizumab for the Treatment of Refractory Systemic Juvenile Idiopathic Arthritis in Thailand. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.